References

Overview of the IL -1 family in innate inflammation and acquired immunity

10.1111/imr.12621 · 2018 · External reference

Structural basis of IL-1 family cytokine signaling

10.3389/fimmu.2019.01412 · 2019 · External reference

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

10.1182/blood-2010-07-273417 · 2011 · External reference

Interleukin expression after injury and the effects of interleukin-1 receptor antagonist

10.1371/journal.pone.0071631 · 2013 · External reference

IL-1 family cytokines in inflammation and immunity

10.1038/s41423-025-01358-8 · 2025 · External reference

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

10.1111/j.1600-065x.2012.01146.x · 2012 · External reference

Pattern recognition receptors: function, regulation and therapeutic potential

10.1038/s41392-025-02264-1 · 2025 · External reference

Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages

10.1182/blood-2008-03-146720 · 2009 · External reference

The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles

10.1091/mbc.10.5.1463 · 1999 · External reference

Phospholipases C and A2 control lysosome-mediated IL-1β secretion: Implications for inflammatory processes

10.1073/pnas.0308558101 · 2004 · External reference

Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages

10.4049/jimmunol.179.3.1913 · 2007 · External reference

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

10.1038/nm1603 · 2007 · External reference

Interleukin 1α and the inflammatory process

10.1038/ni.3503 · 2016 · External reference

A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling

10.1002/eji.1830270139 · 1997 · External reference

The Interleukin-1 Family: Back to the Future

10.1016/j.immuni.2013.11.010 · 2013 · External reference

Mass Spectrometric Analysis of the Endogenous Type I Interleukin-1 (IL-1) Receptor Signaling Complex Formed after IL-1 Binding Identifies IL-1RAcP, MyD88, and IRAK-4 as the Stable Components

10.1074/mcp.m600455-mcp200 · 2007 · External reference

Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2

10.1038/ni.1606 · 2008 · External reference

TRAF6 is a signal transducer for interleukin-1

10.1038/383443a0 · 1996 · External reference

NF-κB signaling in inflammation

10.1038/sigtrans.2017.23 · 2017 · External reference

Tumor necrosis factor receptor-associated factor regulation of nuclear factor κB and mitogen-activated protein kinase pathways

10.3389/fimmu.2018.01849 · 2018 · External reference

IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance

10.4110/in.2024.24.e21 · 2024 · External reference

IL-1 receptor 2 (IL-1R2) and its role in immune regulation

10.1016/j.bbi.2012.11.006 · 2013 · External reference

IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

10.1038/s41590-022-01160-y · 2022 · External reference

M. Interleukin-1 receptor antagonist: From synthesis to therapeutic applications

10.32604/biocell.2023.025850 · 2023 · External reference

Interleukin-1 (IL-1)

2010 · External reference

Tumors: Wounds That Do Not Heal

10.1056/nejm198612253152606 · 1986 · External reference

Tumors vs. Chronic Wounds: An Immune Cell’s Perspective

10.3389/fimmu.2019.02178 · 2019 · External reference

Interleukin-1 in tumor progression, therapy, and prevention

10.1016/j.ccell.2021.04.011 · 2021 · External reference

Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment

10.1158/1078-0432.ccr-18-2202 · 2019 · External reference

Cancer‑associated fibroblast stimulates cancer cell invasion in an interleukin‑1 receptor (IL‑1R)‑dependent manner

2019 · External reference

Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity

10.1158/1078-0432.ccr-22-1031 · 2023 · External reference

The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression

2003 · External reference

The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response

10.4049/jimmunol.1202769 · 2013 · External reference

A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression

10.1172/jci163802 · 2023 · External reference

Fibroblasts: Origins, definitions, and functions in health and disease

10.1016/j.cell.2021.06.024 · 2021 · External reference

Fibroblasts—Warriors at the intersection of wound healing and disrepair

10.3390/biom13060945 · 2023 · External reference

Human Skin Fibroblasts as an In Vitro Model Illustrating Changes in Collagen Levels and Skin Cell Migration Under the Influence of Selected Plant Hormones

10.3390/bioengineering11121188 · 2024 · External reference

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation

1997 · External reference

FGFR signaling establishes spatial gradients of secretory cell identities along the airway proximal-distal axis

10.1038/s41467-026-70842-0 · 2026 · External reference

Dermal Fibroblasts Promote Alternative Macrophage Activation Improving Impaired Wound Healing

10.1016/j.jid.2016.11.035 · 2017 · External reference

The diverse nature of intestinal fibroblasts in development, homeostasis, and disease

10.1016/j.tcb.2023.03.007 · 2023 · External reference

Effects of embryonic origin, tissue cues and pathological signals on fibroblast diversity in humans

10.1038/s41556-025-01638-5 · 2025 · External reference

Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development

10.1016/j.devcel.2020.02.003 · 2020 · External reference

Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis

10.1371/journal.pbio.3001032 · 2020 · External reference

Fibroblast Memory in Development, Homeostasis and Disease

10.3390/cells10112840 · 2021 · External reference

Fibroblasts in intestinal homeostasis, damage, and repair

10.3389/fimmu.2022.924866 · 2022 · External reference

Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)

2024 · External reference

IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer

10.1038/s41467-023-39953-w · 2023 · External reference

Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis

10.1038/s41388-020-01424-7 · 2020 · External reference

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice

10.3390/cells13242058 · 2024 · External reference

The biology and function of fibroblasts in cancer

10.1038/nrc.2016.73 · 2016 · External reference

Cancer-associated fibroblasts: central players in cancer hallmarks and therapeutic resistance

10.1186/s12964-025-02516-1 · 2025 · External reference

Hallmarks of cancer—Then and now, and beyond

10.1016/j.cell.2025.12.049 · 2026 · External reference

Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors

10.1155/2010/695162 · 2010 · External reference

Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin

2012 · External reference

search of definitions: Cancer-associated fibroblasts and their markers

10.1002/ijc.32193 · 2020 · External reference

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

10.1126/science.1254257 · 2014 · External reference

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

10.3390/ijms17122142 · 2016 · External reference

Method of the Year: spatially resolved transcriptomics

10.1038/s41592-020-01033-y · 2021 · External reference

Integration of Single-Cell RNA-Seq Datasets: A Review of Computational Methods

10.14348/molcells.2023.0009 · 2023 · External reference

Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data

10.1016/j.cels.2018.11.005 · 2019 · External reference

Transcription factors in fibroblast plasticity and CAF heterogeneity

10.1186/s13046-023-02934-4 · 2023 · External reference

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment

10.1038/s41467-022-34395-2 · 2022 · External reference

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

10.1084/jem.20162024 · 2017 · External reference

IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma

10.1158/2159-8290.cd-18-0710 · 2019 · External reference

Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity

10.1038/s41588-024-01914-4 · 2024 · External reference

Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response

10.1186/s12943-024-02191-9 · 2025 · External reference

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

10.1158/2159-8290.cd-19-0094 · 2019 · External reference

Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response

10.1038/s41467-025-57465-7 · 2025 · External reference

Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer

10.1016/j.ccell.2022.11.005 · 2022 · External reference

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers

10.1038/s41467-018-03348-z · 2018 · External reference

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

10.1016/j.ccell.2018.01.011 · 2018 · External reference

Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer

10.1158/2159-8290.cd-19-1384 · 2020 · External reference

Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

10.1038/s41467-024-47068-z · 2024 · External reference

The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas

10.1002/ctm2.1516 · 2023 · External reference

Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy

10.1038/s41467-024-53908-9 · 2024 · External reference

Cancer-associated fibroblasts: Recent advances and therapeutic implications

10.1016/j.ceb.2025.102601 · 2026 · External reference

Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines

10.1158/0008-5472.can-22-2316 · 2023 · External reference

Diversity and Biology of Cancer-Associated Fibroblasts

10.1152/physrev.00048.2019 · 2021 · External reference

Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies

10.3390/ijms21176009 · 2020 · External reference

KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

10.1016/j.ccr.2011.12.006 · 2012 · External reference

Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer

10.1038/s41389-022-00434-2 · 2022 · External reference

SMAD4 and KRAS Status Shapes Cancer Cell–Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer

10.1158/0008-5472.can-24-2330 · 2025 · External reference

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

10.2147/hp.s93413 · 2015 · External reference

Hypoxic microenvironment determines the phenotypic plasticity and spatial distribution of cancer-associated fibroblasts

10.1002/ctm2.1438 · 2023 · External reference

ELF3 Mediates IL -1α Induced Differentiation of Mesenchymal Stem Cells to Inflammatory iCAFs

10.1002/stem.3455 · 2021 · External reference

The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation

10.3390/ijms22094960 · 2021 · External reference

IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment

10.1007/s10120-022-01352-3 · 2023 · External reference

NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

10.1016/j.celrep.2025.116849 · 2026 · External reference

IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer

10.1038/s41586-023-06685-2 · 2023 · External reference

Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study

10.7554/elife.78921 · 2022 · External reference

NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis

10.1038/s41467-019-12370-8 · 2019 · External reference

Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer

10.1038/s44318-025-00542-w · 2025 · External reference

Intratumoral Fusobacterium nucleatum Drives Cancer-Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma

10.1002/ags3.70116 · 2026 · External reference

Fusobacterium nucleatum increases CTGF expression through TLR2-YAP signaling axis in cancer-associated fibroblasts, thereby promoting colorectal cancer progression

10.1186/s12935-025-04023-2 · 2025 · External reference

Preprint at

2025 · External reference

Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression

10.1038/s41467-025-58748-9 · 2025 · External reference

TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor

10.1038/s41389-021-00302-5 · 2021 · External reference

Interleukin-1 beta signaling in cancer: A double-edged sword in inflammation and tumorigenesis

10.36922/cp025310046 · 2025 · External reference

Synthetic immune niches for cancer immunotherapy

10.1038/nri.2017.89 · 2018 · External reference

Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer

10.1038/s41467-025-64839-4 · 2025 · External reference

Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors

1986 · External reference

Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity

10.1084/jem.168.6.2031 · 1988 · External reference

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

10.1084/jem.20100050 · 2010 · External reference

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer

10.1038/ncomms1239 · 2011 · External reference

Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells

10.1080/2162402x.2015.1039763 · 2016 · External reference

The plasticity of cancer-associated fibroblasts

10.1016/j.trecan.2025.04.012 · 2025 · External reference

Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment

10.1136/jitc-2024-009523 · 2024 · External reference

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

10.1016/j.ccell.2022.01.004 · 2022 · External reference

Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer

10.1158/1535-7163.mct-21-0083 · 2021 · External reference

Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer

10.1136/jitc-2025-013175 · 2025 · External reference

IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer

10.1007/s00262-025-04138-5 · 2025 · External reference

Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy

10.1007/s00262-022-03277-3 · 2023 · External reference

Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment

10.1016/j.cytogfr.2022.07.006 · 2022 · External reference

Interleukin-6 serves as a critical factor in various cancer progression and therapy

10.1007/s12032-024-02422-5 · 2024 · External reference

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells

10.18632/oncotarget.11786 · 2016 · External reference

Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival

10.1053/j.gastro.2016.03.010 · 2016 · External reference

An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment

10.3390/biomedicines13122966 · 2025 · External reference

The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer

10.1186/s40425-019-0521-4 · 2019 · External reference

Precision Medicine: IL-1RA and Pancreatic Cancer Organoids

10.3390/biology14060604 · 2025 · External reference

An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ

10.1016/j.ymthe.2022.06.010 · 2022 · External reference

Unresolved reference

2026 · External reference

Neutrophils in the Tumor Microenvironment

2020 · External reference

Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis

10.1074/jbc.m115.644823 · 2015 · External reference

IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability

2020 · External reference

Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma

10.1007/s00535-025-02273-5 · 2025 · External reference

A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells

10.1007/s00011-018-1145-8 · 2018 · External reference

The role of interleukin -1 family in fibrotic diseases

10.1016/j.cyto.2023.156161 · 2023 · External reference

IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19

10.1159/000524560 · 2022 · External reference

Proinflammatory Cytokine IL-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction

10.4049/jimmunol.169.1.469 · 2002 · External reference

Infiltration of COX-2–expressing macrophages is a prerequisite for IL-1β–induced neovascularization and tumor growth

10.1172/jci23298 · 2005 · External reference

Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment

10.1016/j.immuni.2022.07.001 · 2022 · External reference

Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity

10.3389/fimmu.2025.1515390 · 2025 · External reference

IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts

10.1186/s12964-025-02575-4 · 2025 · External reference

Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation

10.1073/pnas.1812266115 · 2019 · External reference

Tumor microenvironment and cancer therapy resistance

10.1016/j.canlet.2015.07.044 · 2016 · External reference

Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy

10.1038/s41467-021-26407-4 · 2021 · External reference

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

10.1038/nature11183 · 2012 · External reference

Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling

10.1016/j.ccell.2015.03.008 · 2015 · External reference

Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A

10.1084/jem.20131195 · 2013 · External reference

Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment

10.3892/mmr.2016.4868 · 2016 · External reference

Transcriptomic Insights into the Association of IL-1 Signaling with the Senescence-Associated Secretory Phenotype in Human Fibroblasts

10.3390/genes17050527 · 2026 · External reference

IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy

10.3389/fcell.2022.1083743 · 2023 · External reference

Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network

10.1073/pnas.0905299106 · 2009 · External reference

Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role

10.1128/mcb.00586-18 · 2019 · External reference

Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma

10.1158/0008-5472.can-24-1185 · 2025 · External reference

Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer

10.1158/2159-8290.cd-23-0428 · 2024 · External reference

TSPAN8+ myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer

10.1126/scitranslmed.adj5705 · 2024 · External reference

PI3K and MAPK Signaling Nodes Serve as Divergent Drivers of Phenotypic Plasticity in Cancer-Associated Fibroblasts in Colorectal Cancer

10.1158/0008-5472.can-25-0766 · 2026 · External reference

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

10.1038/s41467-024-54975-8 · 2024 · External reference

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer

10.1158/1078-0432.ccr-20-3715 · 2021 · External reference

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

10.1002/art.43384 · 2026 · External reference

Therapeutic Strategies for Targeting IL-1 in Cancer

10.3390/cancers13030477 · 2021 · External reference

Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

10.4065/84.2.114 · 2009 · External reference

Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma

10.1002/ajh.24352 · 2016 · External reference

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

10.1016/s1470-2045(14)70155-x · 2014 · External reference

Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer

10.1007/s10637-015-0226-6 · 2015 · External reference

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

10.1056/nejmoa1707914 · 2017 · External reference

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(17)32247-x · 2017 · External reference

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

10.1200/jco.23.00910 · 2024 · External reference

10.1016/j.lungcan.2023.107451

10.1016/j.lungcan.2023.107451 · 2024 · External reference

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

10.1200/jco.23.00980 · 2024 · External reference

CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC

2025 · External reference

Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment

10.20892/j.issn.2095-3941.2025.0288 · 2025 · External reference

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma

10.2147/itt.s291767 · 2021 · External reference

The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials

10.1158/2767-9764.crc-24-0490 · 2025 · External reference

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

10.1016/j.ccr.2014.04.005 · 2014 · External reference

Insights into the relevance of targeting fibroblasts to control cancer

2025 · External reference

αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression

10.1038/s41388-021-01866-7 · 2021 · External reference

Activated fibroblasts in cancer: Perspectives and challenges

10.1016/j.ccell.2023.02.015 · 2023 · External reference

Spatial and temporal dynamics of cancer-associated fibroblast niches in breast cancer

10.1186/s13058-025-02183-7 · 2026 · External reference

Crosstalk Between Cancer-Associated Fibroblasts and Immune Cells: Mechanisms and Therapeutic Implications

2025 · External reference

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer

10.1038/nm.3646 · 2014 · External reference

Cre reconstitution allows for DNA recombination selectively in dual-marker-expressing cells in transgenic mice

10.1093/nar/gkm559 · 2007 · External reference

Unresolved reference

2026 · External reference